Summary
In patients with Haemophilia A, the development of inhibitor is a life-threatening complication of treatment. These patients are at high risk for dangerous bleeding as a result of this acquired resistance to human Factor VIII concentrate. Although treatment of bleeding complications has been improved with the introduction of an activated prothrombin complex preparation, therapy remains unsatisfactory. Two patients with Haemophilia A inhibitor were treated with high dose intravenous immunoglobulin in the expectation of an immunosuppressive effect. A rise in the antibody titre at the same time as the administration of factor VIII concentrate showed that this treatment was ineffective in patients with Haemophilia A inhibitor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abildgaard CF (1976) Management of inhibitors in hemophilia. In: Hilgartner MW (ed) Hemophilia in children. Publishing Sciences Group Inc, Littleton Mass, pp 171
Allain JP, Roberts HR (1975) Treatment of acute bleeding episodes in hemophilic patients with specific factor VIII antibodies. In: Brinkhous KM, Hemker HC (eds) Handbook of haemophilia. Excerpta Medica, Amsterdam, p 659
Bennett B, Ratnoff WS (1972) Immunological relationships of antihemophilic factor of different species detected by specific human and rabbit ABs. Proc Soc Exp Biol Med 148: 701
Biggs R (1978) The treatment of hemophilia A and B and von Willebrand's disease. Blackwell, Oxford
Blatt PM, White GC, McMillan CW, Roberts HR (1977) Treatment of anti-factor VIII antibodies. Thromb Haemost 38: 514
Brackmann HH, Etzel R, Hoffmann P, Egli H (1977) The successful treatment of acquired inhibitors against factor VIII. Thromb Haemost 38: 369
Brinkhous KM, Shanbromm E, Roberts HR, Webster WP, Fekete L, Wagner RH (1968) A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. JAMA 205: 613
Durandy A, Fischer A, Griscelli (1980) Induction by gammaglobulin therapy of T and B lymphocyte dysfunction in the in vitro PWM system. In: Seligmann M, Hitzig WH (eds) Primary immunodeficiencies. INSERM Symposium No 16. Elsevier/North Holland, Biomedical Press, p 151
Evensen SA, Thaule R, Grøan K (1979) Selftherapy for hemophilia in Norway. Acta Med Scand 205: 395
Ikkala E, Simonen O (1971) Factor VIII inhibitors and the use of blood products with haemophilia A. Scand J Haematol 8: 16
Imbach P, d'Apuzzo V, Hirt A, Rossi E, Vest M, Barandun S, Baumgartner C, Morell A, Schöni M, Wagner P (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228
Kaspar CK (1975) A more uniform measurement of F VIII inhibitors. Thromb Diath Haemorrh 34: 869
Kaspar CK (1973) Incidence and Course of Inhibitors among Patients with classic Hemophilia. Thromb Diath Haemorrh 30: 263
Kelly P, Penner JA (1976) Antihemophilic factor inhibitors management with prothrombin complex concentrates. J Am Med Assoc 236: 2061
Ledermann MM, Ratnoff OD, Scillian JJ, Jones PK, Schacter B (1983) Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med 2: 79
McMillan (1981) Chronic idiopathic thombocytopenic purpura. N Engl J Med 304: 1135
Nilsson JM, Hedner U, Holmberg L (1974) Suppression of Factor VIII antibody by combined Factor VIII and cyclophosphamide. Acta Med Scand 195: 65
Poon MC, Wine AC, Ratnoff OD, Bernier GM (1975) Heterogeneity of human circulating anticoagulants against antihaemophilic factor (factor VIII). Blood 46: 409
Roberts HR, Knowles MR, Jones TL, McMillan CW (1970) Use of factor VIII concentrates in the management of patients with factor VIII inhibitors. In: Brinkhous KM (ed) Hemophilia and new hemorrhagic states. University of North Carolina Press, Chapel Hill
Seifried E, Pindur G, Stötter H, Porzsolt F, Rasche H, Heimpel H (1983) Klinische und labordiagnostische Untersuchungen bei Patienten mit Haemophilie A und B unter besonderer Berücksichtigung von Regulationsstörungen des Immunsystems. Hameophilie Symposium, in press
Shapiro SS, Hultin M (1975) Acquired inhibitors to the blood coagulation factors. Semin Thromb Hemost 1: 336
Shapiro SS (1975) Characterization of Factor VIII antibodies. Ann N Y Acad Sci 240: 350
Strauss HS (1975) Acquired circulating anticoagulants in hemophilia A. N Engl J Med 292: 754
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seifried, E., Gaedicke, G., Pindur, G. et al. The treatment of haemophilia a inhibitor with high dose intravenous immunoglobulin. Blut 48, 397–401 (1984). https://doi.org/10.1007/BF00319971
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00319971